SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062958
Filing Date
2023-11-13
Accepted
2023-11-13 16:14:54
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dsgn-20230930.htm   iXBRL 10-Q 2567788
2 EX-10.1 dsgn-ex10_1.htm EX-10.1 103255
3 EX-31.1 dsgn-ex31_1.htm EX-31.1 19961
4 EX-32.1 dsgn-ex32_1.htm EX-32.1 13266
5 GRAPHIC img80669102_0.jpg GRAPHIC 12147
  Complete submission text file 0000950170-23-062958.txt   8870329

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dsgn-20230930_def.xml EX-101.DEF 133266
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dsgn-20230930_pre.xml EX-101.PRE 246216
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dsgn-20230930_lab.xml EX-101.LAB 342032
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dsgn-20230930_cal.xml EX-101.CAL 41775
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dsgn-20230930.xsd EX-101.SCH 43538
59 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20230930_htm.xml XML 1879665
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 231398898
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences